4//SEC Filing
Klein Lawrence Otto 4
Accession 0001209191-21-068455
CIK 0001674416other
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 8:00 PM ET
Size
9.2 KB
Accession
0001209191-21-068455
Insider Transaction Report
Form 4
Klein Lawrence Otto
Chief Business Officer
Transactions
- Exercise/Conversion
Common Shares
2021-12-03+26,667→ 33,510 total - Tax Payment
Common Shares
2021-12-06$69.17/sh−11,185$773,666→ 22,325 total - Exercise/Conversion
Restricted Stock Units
2021-12-03+26,667→ 13,333 total→ Common Shares (26,667 underlying)
Footnotes (3)
- [F1]The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022.
- [F2]Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
- [F3]On December 3, 2019, the reporting person was granted 40,000 restricted stock units. On December 3, 2021, 26,667 restricted stock units vested. Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.
Documents
Issuer
CRISPR Therapeutics AG
CIK 0001674416
Entity typeother
Related Parties
1- filerCIK 0001762583
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 8:00 PM ET
- Size
- 9.2 KB